Universitat de València;Institut Químic de Sarrià CETS Fundació Privada;Institut Univ. de Ciència i Tecnologia, S.A.
发明人:
申请号：
EP15797925.3
公开号：
EP3217985B1
申请日:
2015.11.13
申请国别(地区):
EP
年份:
2018
代理人:
摘要：
The present invention relates to a compound of formula (I), provided that this compound is not caffeine, for use in the treatment of myotonic dystrophy type 1 and type 2. The present invention also relates to compositions comprising the compound of formula (I) as defined herein. The present invention further relates to new compounds which are dimers of compounds of formula (I).
